PIK3CA and cancer: Shortly after, the same group further showed that PIK3CA-mutant cancer cells sensitive to BYL719 tend to potently inhibit phosphorylation of retinoblastoma protein (RB), a substrate of CDK4/6, whereas resistant cells failed to do so[70].